REGN vs GILD: Which Stock is Better?
Side-by-side comparison of Regeneron Pharmaceuticals Inc and Gilead Sciences Inc in 2026
REGN
Regeneron Pharmaceuticals Inc
$614.78
GILD
Gilead Sciences Inc
$134.43
Key Metrics Comparison
| Metric | REGN | GILD | Winner |
|---|---|---|---|
| Market Cap | $65.81B | $165.99B | GILD |
| P/E Ratio | 15.34 | 18.19 | REGN |
| EPS (TTM) | $40.93 | $7.35 | REGN |
| Revenue Growth | 0.2% | 0.0% | REGN |
| Gross Margin | 43.9% | 79.4% | GILD |
Analyze REGN
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REGN or GILD a better investment?
Comparing REGN and GILD: Regeneron Pharmaceuticals Inc has a market cap of $65.81B while Gilead Sciences Inc has $165.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REGN and GILD?
REGN (Regeneron Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REGN or GILD?
Based on P/E ratios, REGN trades at a lower multiple (15.3x vs 18.2x).
Which is growing faster: REGN or GILD?
REGN has higher revenue growth at 0.2% vs 0.0% for GILD.
Which company is more profitable: REGN or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 79.4% compared to 43.9% for REGN.
Which is the larger company: REGN or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $165.99B compared to $65.81B for REGN.
Should I buy REGN or GILD in 2026?
Both REGN and GILD have investment merit. REGN trades at $614.78 while GILD trades at $134.43. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REGN and GILD stock?
Key differences: Market Cap ($65.81B vs $165.99B), P/E Ratio (15.3x vs 18.2x), Revenue Growth (0.2% vs 0.0%), Gross Margin (43.9% vs 79.4%).